TriReme allies with major China distributor for PAD devices

TriReme Medical has China in its sights as part of a major push to expand. The maker of coronary and peripheral artery disease treatment devices inked a deal with Weihai Weigao Medical Devices to distribute its products to hospitals and other health care venues throughout the country--a massive emerging market for life sciences products. Neither side is disclosing financial terms. But Weihai Weigao is one of China's largest domestic distributors of medical products, with a customer base that includes more than 2,700 hospitals and 21,500 distribution or trading partners across the country, TriReme notes. TriReme, which is based in California and Singapore, has focused on growth in Asia as a major piece of its expansion strategy. Story

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.